These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 6003408)
1. Pharmacological properties of 1-(4'-nitropheynl)-2-isopropylamino-ethanol (INPEA) a new beta-adrenergic receptor antagonist. 3. Direct effects on heart rate, oxygen consumption and rectal temperature and effects on the cardiac and metabolic responses to isoproterenol, adrenaline and noradrenaline in the urethan anesthetized rat. Murmann W; Rumore G; Gamba A Boll Chim Farm; 1966 Jul; 105(7):512-35. PubMed ID: 6003408 [No Abstract] [Full Text] [Related]
2. Pharmacological properties of 1-(4'-nitrophenyl)-2-isopropylamino-ethanol (INPEA), a new beta-adrenergic receptor antagonist. V. Effects of the optical isomers D(minus) and L(plus) INPEA on heart rate, oxygen consumption and body temperature and on the cardiac and metabolic effects of adrenaline and noradrenaline in urethane-anesthetized rats. Murmann W; Rumore G; Gamba A Boll Chim Farm; 1967 Apr; 106(4):251-68. PubMed ID: 5613020 [No Abstract] [Full Text] [Related]
3. Pharmacological properties of 1-(4'-nitrophenyl)-2-isopropylamino-ethanol (INPEA), a new beta-adrenergic receptor antagonist. IV. Effects of the optical isomers D (minus) and L (plus) INPEA on the arterial pressure and on the pressor responses to noradrenaline, adrenaline and isoproterenol in urethan-anesthetised rats. Murmann W; Gamba A Boll Chim Farm; 1967 Feb; 106(2):101-8. PubMed ID: 5608202 [No Abstract] [Full Text] [Related]
4. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent]. Brunner H; Hedwall PR; Meier M Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373 [No Abstract] [Full Text] [Related]
6. Relationship between configuration and adrenergic beta-receptor blocking activity of optical isomers of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA). Almirante L; Murmann W J Med Chem; 1966 Sep; 9(5):650-3. PubMed ID: 5969031 [No Abstract] [Full Text] [Related]
7. [Influence of the beta-adrenergic blocking function on the cardiocirculatory changes induced by isoproterenol, adrenaline and noradrenaline in normal subjects studied by a bloodless method]. Barbaresi F; Bacuzzi E; Volta G; Starcich R Mal Cardiovasc; 1967; 8(2):213-23. PubMed ID: 5608782 [No Abstract] [Full Text] [Related]
8. Salivation in mice as an index of adrenergic activity. 3. Partial temperature-dependence of adrenergic drug effects. Maling HM; Koppanyi T Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):344-57. PubMed ID: 4403620 [No Abstract] [Full Text] [Related]
9. [Cardiac action of beta-blocking agents. I. Influence of 1-(4'-nitrophenyl)-2-isopropyl-aminoethanol hydrochloride (1-INPEA)]. Greggia A; Poggioli R Boll Soc Ital Biol Sper; 1968 Jun; 44(11):969-72. PubMed ID: 5687296 [No Abstract] [Full Text] [Related]
10. [Changes in the adrenergic regulation of thermogenesis during prolonged rat adaptation to cold]. Pastukhov IuF Fiziol Zh SSSR Im I M Sechenova; 1980 May; 66(5):739-45. PubMed ID: 7398941 [TBL] [Abstract][Full Text] [Related]
11. Influence of INPEA, pindolol and propranolol on the chronotropic and metabolic responses to -adrenergic stimulation in intact rats. Robak J; Gryglewski R Biochem Pharmacol; 1971 Oct; 20(10):2749-58. PubMed ID: 4398866 [No Abstract] [Full Text] [Related]
12. Influence of oxprenolol on adrenaline-induced reflex bradycardia in dogs. Gagnon DJ Rev Can Biol; 1972 Mar; 31(1):65-7. PubMed ID: 4401590 [No Abstract] [Full Text] [Related]
13. Chronic treatment with catecholamines and the cardiovascular system. LeBlanc J; Vallières J; Bureau M; Labrie A; Deshaies Y; Vachon C Recent Adv Stud Cardiac Struct Metab; 1973; 3():527-32. PubMed ID: 4806666 [No Abstract] [Full Text] [Related]
14. Contribution to the clinical evaluation of beta-adrenergic blocking drugs: 1-p-nitrophenyl-2-isopropylaminoethanol (INPEA) as an antagonist of catecholamines in normal persons and in coronary disease patients. Piva M; Ongari R Arzneimittelforschung; 1968 Feb; 18(2):179-88. PubMed ID: 5695376 [No Abstract] [Full Text] [Related]
15. [Hemodynamic effects of a new beta-adrenergic blocking agent. Study of normal subjects in various cardiocirculatory functional conditions]. Starcich R; Barbaresi F; Bacuzzi E; Valentino RV Minerva Cardioangiol; 1966 Nov; 14(11):650-7. PubMed ID: 5999111 [No Abstract] [Full Text] [Related]
17. [Effect of an adrenergic beta receptor blockader (D(-)INPEA) on various functional parameters of the rabbit heart]. Arrigo L; Macrì I; Rigon-Macrì P Boll Soc Ital Biol Sper; 1971 Oct; 47(20):647-50. PubMed ID: 4401207 [No Abstract] [Full Text] [Related]
18. [Regional hemodynamics in the rat: changes induced by administration of adrenaline and of a beta-blocking drug (INPEA)]. Lauro R; Dogliotti L; Bajardi P; Doglio R; Fonzo D; De Martinis C Boll Soc Ital Biol Sper; 1967 Dec; 43(23):1590-2. PubMed ID: 5589054 [No Abstract] [Full Text] [Related]
19. Heat loss responses and blockade of prostaglandin E2-induced thermogenesis elicited by alpha1-adrenergic activation in the rostromedial preoptic area. Osaka T Neuroscience; 2009 Sep; 162(4):1420-8. PubMed ID: 19465086 [TBL] [Abstract][Full Text] [Related]
20. Thermoregulatory effects of beta adrenoceptors: effects of selective agonists and the interaction of antagonists with isoproterenol and BRL-35135 in the cold. Carlisle HJ; Stock MJ J Pharmacol Exp Ther; 1993 Sep; 266(3):1446-53. PubMed ID: 8103795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]